Stage IV Lung Cancer: Shyreece's Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- Actionable biomarker identified by biomarker testing; specific mutation not stated
- Sex
- Female
- Spread to
- Not reported
- Treatment
- chemotherapy, biomarker testing, targeted therapy, a clinical trial and patient advocacy
- Outcome
- Care Ongoing
Treatment course, step by step
- Initial chemotherapy cocktail
- biomarker testing changed her treatment path
- unnamed targeted therapy pill, which improved quality of life compared with chemotherapy
- participation in a clinical trial. Specific mutation and targeted therapy drug name are not stated in the available video description.
What happened, in summary
Shyreece Pompey’s Stage IV lung cancer care changed when biomarker testing opened a different treatment path. She had first been placed on a chemotherapy cocktail. Later, testing showed that a targeted therapy pill was an option, though the mutation and drug name are not named in this segment. For Shyreece, the switch mattered because the pill gave her a better quality of life than the earlier chemotherapy approach. That experience helped shape how she thought about research and patient choice. She went on to participate in a clinical trial, describing why trials matter: they are how new drugs are tested and may eventually become real options for future patients. This part of her story also returns to self-advocacy. Shyreece emphasizes that patients should speak up when treatment decisions are being made, especially when side effects, quality of life, or alternatives are on the table. As of March 2022, she was living with Stage IV lung cancer, had moved from chemotherapy to an unnamed targeted pill, and was using her clinical-trial experience to support research and encourage patients to ask informed questions. The strongest theme is that treatment decisions can change when testing, research access, and patient questions come together at the right time.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team.